K C Rice|J M Cook - JoVE Visualize

Showing results (201-210 of 475) with videos related to

Pageof 48

Sort By:

Behavioural Pharmacology|November 1, 2002

Delta opioid antagonist effects of buprenorphine in rhesus monkeysS S Negus, J M Bidlack, N K Mello, et al.

Science (New York, N.Y.)|April 15, 1983

Irreversible ligands with high selectivity toward delta and mu opiate receptorsK C Rice, A E Jacobson, T R Burke, et al.

Journal of Medicinal Chemistry|December 1, 1984

Probes for narcotic receptor mediated phenomena. 7. Synthesis and pharmacological properties of irreversible ligands specific for mu or delta opiate receptorsT R Burke, B S Bajwa, A E Jacobson, et al.

Peptides|March 1, 1990

Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brainR B Rothman, V Bykov, B R de Costa, et al.

Endocrinology|December 1, 1996

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammationE L Webster, D B Lewis, D J Torpy, et al.

FEBS Letters|December 13, 1982

Identification of a Mr 58 000 glycoprotein subunit of the opiate receptorW A Klee, W F Simonds, F W Sweat, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1991

Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the ratE J Drower, A Stapelfeld, M F Rafferty, et al.

Molecular Microbiology|February 6, 2015

Examination of the Staphylococcus aureus nitric oxide reductase (saNOR) reveals its contribution to modulating intracellular NO levels and cellular respirationA M Lewis, S S Matzdorf, J L Endres, et al.

Endocrinology|June 30, 1998

A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheepE C Chan, J Falconer, G Madsen, et al.

Synapse (New York, N.Y.)|February 5, 2000

Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuseR B Rothman, J S Partilla, M H Baumann, et al.

Pageof 48

Showing results (201-210 of 475) with videos related to

Sort By:

Pageof 48

Behavioural Pharmacology|November 1, 2002

Delta opioid antagonist effects of buprenorphine in rhesus monkeysS S Negus, J M Bidlack, N K Mello, et al.

Science (New York, N.Y.)|April 15, 1983

Irreversible ligands with high selectivity toward delta and mu opiate receptorsK C Rice, A E Jacobson, T R Burke, et al.

Journal of Medicinal Chemistry|December 1, 1984

Probes for narcotic receptor mediated phenomena. 7. Synthesis and pharmacological properties of irreversible ligands specific for mu or delta opiate receptorsT R Burke, B S Bajwa, A E Jacobson, et al.

Peptides|March 1, 1990

Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brainR B Rothman, V Bykov, B R de Costa, et al.

Endocrinology|December 1, 1996

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammationE L Webster, D B Lewis, D J Torpy, et al.

FEBS Letters|December 13, 1982

Identification of a Mr 58 000 glycoprotein subunit of the opiate receptorW A Klee, W F Simonds, F W Sweat, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1991

Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the ratE J Drower, A Stapelfeld, M F Rafferty, et al.

Molecular Microbiology|February 6, 2015

Examination of the Staphylococcus aureus nitric oxide reductase (saNOR) reveals its contribution to modulating intracellular NO levels and cellular respirationA M Lewis, S S Matzdorf, J L Endres, et al.

Endocrinology|June 30, 1998

A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheepE C Chan, J Falconer, G Madsen, et al.

Synapse (New York, N.Y.)|February 5, 2000

Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuseR B Rothman, J S Partilla, M H Baumann, et al.

Pageof 48